g

 

 

 

Newsroom

Läkemedelsbolaget QPharma i Malmö inleder efter sommaren en förstudie inför en utbyggnad av sina lokaler. Om allt går enligt planerna ska bygget utöka bolagets yta med 2.000 kvadratmeter.

Swedish version



The Dapivirine-Levonorgestrel combination rings we manufactured for IPM in 2015 have now entered a clinical phase I study - Let’s hope for good clinical results!
More information about the product and clinical study is found in the IPM publication below. (May 2017)

English version (external link)



LSR material used in vaginal rings for HIV protection. Research done by Queens University in Belfast and manufacturing by QPharma. (Feb 2017)

English version (external link)



The promise of the ring for women's HIV prevention
This World AIDS Day, women have reason to be optimistic that a new era may be at hand – one in which they could have more choices to protect themselves against HIV. Watch this video to learn about the Dapivirine ring. (Dec 2016)

English version (external link)



On the heels of important evidence that a monthly vaginal ring can help prevent HIV in women, panelists will highlight lessons from the development of the Dapivirine ring. (May 2016)

English version (external link)



Nordic Life Science article on surviving as a CMO, interview with managing directors of both QPharma AB and Orion Pharma AB. (April 2016)

English version (external link)



QPharma närmar sig massproduktion av preventivring. (October 2015)
De kliniska prövningarna av QPharmas egenutvecklade preventivmedelsring för kvinnor i utvecklingsländer är färdiga. Nu väntar registrering och om ett år räknar läkemedelsbolaget med att starta massproduktionen i Malmö. Parallellt siktar bolaget på att dubbla fabriksytan.

Swedish version



QPharma enters agreement with International Partnership for Microbicides
for Future Manufacture of Dapivirine Vaginal Ring for HIV Prevention. (June 2015)

English version



AAA® Financial rating award. (may 2015)
QPharma AB was again awarded the highest credit rating AAA® for the year 2015 by the Swedish financial rating agency Bisnode.
The company has thereby retained this rating during the period 2010-15.



Non-Hormonal contraceptive Intra-Vaginal Ring to be developed by QPharma AB and BioRings LLC. (March 2015)

English version